US2017211057A1PendingUtilityA1
Expression Vector Comprising a Polynucleotide Encoding a Modified Glutamine Synthetase and a Method for Preparing a Target Protein Employing the Same
Est. expiryMar 12, 2032(~5.6 yrs left)· nominal 20-yr term from priority
C07K 2319/30C12N 9/93C12N 2840/203C07K 14/71C12N 15/85A61K 35/12C12Y 603/01002C12N 15/52C12N 9/00C12N 15/63
49
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to a vector comprising a polynucleotide encoding a modified glutamine synthetase (GS), and a method for preparing a target protein employing the same. More particulary, the present invention relates to a modified GS having an increased sensitivity to a glutamine synthetase (GS) inhibitor, a polynucleotide encoding the modified GS, a vector comprising the polynucleotide, a transformat comprising the vector, and a method for preparing a target protein using the transformat.
Claims
exact text as granted — not AI-modified1 . A modified glutamine synthetase (GS), wherein glycine (Gly, G) at position 299 of a glutamine synthetase having an amino acid sequence shown in SEQ ID NO. 4 is substituted with arginine (Arg, R).
2 . The modified glutamine synthetase according to claim 1 , having an increased sensitivity to a glutamine synthetase inhibitor, compared to the glutamine synthetase having an amino acid sequence shown in SEQ ID NO.4.
3 . The modified glutamine synthetase according to claim 2 , wherein the glutamine synthetase inhibitor is selected from the group consisting of glycine, alanine, tryptophan, histidine, glucosamine-6-phosphate, cytidine triphosphate, methionine sulphoximine (MSX), and combinations thereof.
4 . (canceled)
5 . (canceled)
6 . (canceled)
7 . (canceled)
8 . (canceled)
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . (canceled)
14 . (canceled)
15 . (canceled)
16 . A target protein prepared by a method comprising culturing a transformant comprising a vector for expression of a target protein, comprising the polynucleotide encoding a modified glutamine synthetase wherein glycine (Gly, G) at position 299 of a glutamine synthetase having an amino acid sequence shown in SEQ ID NO. 4 is substituted with arginine (Arg, R).Join the waitlist — get patent alerts
Track US2017211057A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.